Sylvia Adams
Clinical Associate Professor · NYU Grossman Long Island School of Medicine
Credentials: · ·
History
- 1991–1995
from Friedrich Schiller University Jena
Research
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
New England Journal of Medicine · 2018 · 3,425 citations
Annals of Oncology · 2015 · 2,547 citations
Journal of Clinical Oncology · 2014 · First of 16 authors · 1,031 citations
- SD
30 papers
22 papers
- DR
13 papers
13 papers
12 papers
11 papers
- DO
10 papers
10 papers
Grants
- 2011–2016
Immunomodulation of Breast Cancer via TLR7 Agonist Imiquimod and Radiotherapy.
National Cancer Institute · R01
PI · $1.7M · Weill Medical Coll of Cornell Univ
- 2007–2013
Augmenting Cancer Vaccine Therapy with TLR9 Agonists
National Cancer Institute · K23
Contact PI · $690.9K · New York University School of Medicine
Clinical trials
- 2016–2020
Presurgical Trial of Denosumab in Breast Cancer
Principal investigator · Completed · Early phase 1
NYU Langone Health
- 2013–2017
Exemestane and Cyclophosphamide for Metastatic Breast Cancer
Principal investigator · Completed · Phase 2
NYU Langone Health
- 2011–2016
Principal investigator · Completed · Phase 1, Phase 2
NYU Langone Health
- 2009–2013
Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases
Principal investigator · Completed · Phase 2
NYU Langone Health